|
WDR20 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.54499999963187E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03380000004982E-07 |
| Normal-vs-Stage2 |
4.162100E-03 |
| Normal-vs-Stage3 |
3.236100E-03 |
| Normal-vs-Stage4 |
2.44080000000313E-06 |
| Stage1-vs-Stage2 |
9.115800E-01 |
| Stage1-vs-Stage3 |
9.564000E-01 |
| Stage1-vs-Stage4 |
2.945200E-01 |
| Stage2-vs-Stage3 |
9.007600E-01 |
| Stage2-vs-Stage4 |
2.679200E-01 |
| Stage3-vs-Stage4 |
3.932400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1738999994293E-08 |
| Normal-vs-AfricanAmerican |
3.840100E-04 |
| Normal-vs-Asian |
6.157200E-03 |
| Caucasian-vs-AfricanAmerican |
3.289400E-01 |
| Caucasian-vs-Asian |
9.964800E-01 |
| AfricanAmerican-vs-Asian |
7.345600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.96119997808842E-09 |
| Normal-vs-Female |
1.278210E-03 |
| Male-vs-Female |
2.126000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.041810E-03 |
| Normal-vs-Extreme_Weight |
4.96859999810084E-08 |
| Normal-vs-Obese |
7.243400E-04 |
| Normal-vs-Extreme_Obese |
8.321900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.850000E-01 |
| Normal_Weight-vs-Obese |
5.450600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.936600E-01 |
| Extreme_Weight-vs-Obese |
7.921600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.159200E-01 |
| Obese-vs-Extreme_Obese |
7.006400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.598900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.431180E-04 |
| Normal-vs-Age(61-80Yrs) |
3.67609997997675E-09 |
| Normal-vs-Age(81-100Yrs) |
1.05200000000139E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.621200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.887400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.997500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.660100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.631900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.624000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.1845999999608E-07 |
| Normal-VS-Type2 PRCC |
6.42630004765721E-09 |
| Normal-VS-KIRP CIMP |
8.563800E-03 |
| Normal-VS-Unclassified PRCC |
4.518800E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.854200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.109200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.690800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.724000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.415560E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.931200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.12730000071338E-09 |
| Normal-vs-N1 |
1.392330E-02 |
| Normal-vs-N2 |
4.97290000289752E-08 |
| N0-vs-N1 |
5.382200E-02 |
| N0-vs-N2 |
9.19959999956532E-07 |
| N1-vs-N2 |
7.13379999961461E-07 |
|
|
